AMT vs EDIT · P/E 31, rev $2.55B vs rev $32.3M
American Tower Corp (AMT) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported AMT revenue for 2024-12-31 was $2.55B. Net income was $2.28B. Revenue was up 1.0% from 2024-09-30 to 2024-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the AMT and EDIT stock pages for the full models.
Not investment advice.